The EVERY Company
PrivateLast Round
Series D
Nov 4, 2025
Est. Valuation
$625,000
Total Funding Raised
$296.75M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
The EVERY Company operates in Healthcare & Life Sciences and is based in Daly City, California. Its latest recorded funding round was a Series D round in November 2025.
The EVERY Company is a food technology company that produces animal-free protein ingredients using precision fermentation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Circular Economy
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
The EVERY Company Comparables
Compare The EVERY Company with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Onego Bio | 90% | |
| Perfect Day | 86% | |
| MycoTechnology | 86% |
For institutional investors. Book with your work email.
The EVERY Company Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Nov 4, 2025 | ||||
| Grant | Dec 2, 2024 | ||||
| Series C | Dec 7, 2021 | ||||
| Debt | Jan 14, 2021 | ||||
| Series B | Apr 25, 2019 | ||||
Series A | Jul 1, 2016 |
For institutional investors. Book with your work email.
The EVERY Company Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Prosus | Series C |
| The Production Board | Series A |
| B37 Ventures | Series B |
| Temasek | Series C |
| Rosebrook (EU) | Series C |
| Main Sequence | Series D |
| Grosvenor Food & AgTech | Series D, Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 23, 2025
Grew 16% QoQ, from 111 to 129 employees.
- Nov 4, 2025
$55M round led by McWin Capital Partners.
For institutional investors. Book with your work email.
The EVERY Company Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about The EVERY Company's valuation, stock price, and market status.
Is The EVERY Company a public or private company?
The EVERY Company is a private company.
What is the current stock price of The EVERY Company?
The EVERY Company is a private company, so its shares have no public market price. Caplight tracks The EVERY Company's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is The EVERY Company worth (valuation)?
The EVERY Company's valuation is estimated at $625.0K based on funding round data.
Can I buy The EVERY Company stock?
The EVERY Company shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was The EVERY Company's last funding round?
The EVERY Company's most recent funding round was Series D on November 4, 2025.
Who are the main investors in The EVERY Company?
Key investors in The EVERY Company include The Production Board, McWin Capital Partners, IndieBio, Horizon Technology Finance Corporation, Bloom8.
Will The EVERY Company IPO soon?
No public IPO plans have been announced for The EVERY Company.
How can I track The EVERY Company secondary market activity?
Caplight tracks bids, offers, and trades in The EVERY Company's shares on secondary markets.